Endra Life Sciences announced its board of directors has appointed Alexander Tokman as acting CEO to replace Francois Michelon, who stepped down from his role as CEO and as a member of the board of directors to pursue other endeavors. The company also announced the addition to its senior management team of Ziad Rouag as head of regulatory and clinical affairs and Richard Jacroux as CFO.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NDRA: